OMNIPAQUE ™ (iohexol) injection is a nonionic, x-ray or radiographic contrast medium for intrathecal, intravenous, oral, rectal and body cavity use.

Iohexol (radiopaque) Uses:

  • Imaging: Adults:

    • Intrathecal:

      • Iohexol 180, 240, and 300: contrast enhancement for CT (myelography, cisternography, ventriculography), and Myelography (lumbar, thoracic, cervical, and total columnar)

    • Intravascular:

      • Iohexol 140:

        • Intra-arterial digital subtraction angiography of head, neck, abdominal, renal, and peripheral vessels
      • Iohexol 240:

        • Contrast enhancement for CT head imaging and peripheral venography (phlebography)
      • Iohexol 300:

        • for Aortography (including studies of the arch of aorta, abdominal aorta, and its branches], contrast enhancement for CT head and body, peripheral venography i.e phlebography, cerebral arteriography, and excretory urography
      • Iohexol 350:

        • Angiocardiography (ventriculography, selective coronary arteriography), contrast enhancement for CT head and body, aortography (including studies of the root of the aorta, arch of aorta, ascending aorta, abdominal aorta [and branches]), intravenous digital subtraction angiography of head, neck, abdominal renal and peripheral vessels, peripheral arteriography, and excretory urography
      • Iohexol 300 (bulk) and 350 (bulk):

        • Contrast enhancement for CT head and body imaging (for IV administration with an appropriate automated contrast injection system, contrast management system, or contrast media transfer set)

    • Oral:

      • Iohexol 350:

        • Oral radiography examination of the gastrointestinal tract
    • Oral in conjunction with IV administration:

      • Iohexol 240, 300, and 350 (diluted; oral) and Iohexol 300 (IV):

        • Contrast-enhanced abdomen CT
      • Iohexol (oral solution 9 and 12) and Iohexol 300 (IV):

        • Contrast-enhanced abdomen CT
    • Intraarticular:

      • Iohexol 240, 300, and 350: Arthrography
    • Body cavity:

      • Iohexol 240:

        • Endoscopic retrograde pancreatography (ERP) and cholangiopancreatography (ERCP), herniography, and hysterosalpingography
      • Iohexol 300:

        • Hysterosalpingography

    • Oral:

      • Iohexol (Oraltag):

        • Contrast enhancement for CT abdomen and pelvis imaging to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology
    • Limitations of use:
      • Oraltag is not indicated for diagnostic examination of the GI tract.

  • Imaging: Pediatrics:

    • Intrathecal:

      • Iohexol 180:

        • Myelography (lumbar, thoracic, cervical, and total columnar), and contrast enhancement for CT (myelography, cisternography)
    • Intravascular:
      • Iohexol 240:

        • Contrast enhancement for CT head and body imaging
      • Iohexol 300:

        • Angiocardiography (ventriculography), contrast enhancement for CT head and body imaging, and excretory urography
      • Iohexol 350:

        • Angiocardiography (ventriculography, pulmonary arteriography, venography, and studies of collateral arteries);
        • aortography, including the root of aorta, arch of aorta, ascending and descending aorta)
      • Iohexol 300 (bulk):

        • Contrast enhancement for CT head and body imaging (for IV administration with an appropriate automated contrast injection system, contrast management system, or contrast media transfer set)
    • Oral or rectal:

      • Iohexol 180, 240, and 300:

        • Oral and rectal radiographic examination of the gastrointestinal tract
    • Oral in conjunction with IV administration:

      • Iohexol 240, 300, and 350 (diluted; oral) and Iohexol 240 or 300 (IV):

        • Contrast-enhanced abdomen CT
      • Iohexol (oral solution 9 and 12) and Iohexol 240 or 300 (IV):

        • Contrast-enhanced abdomen CT
    • Body cavity:

      • Iohexol 240, 300, and 350 (diluted):

        • Voiding cystourethrography (VCUG)
    • Oral:

      • Iohexol (Oraltag):

        • Contrast enhancement for CT abdomen and pelvis imaging to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology
    • Limitations of use:

      • Oraltag is not indicated for diagnostic examination of the GI tract.

Reviews

There are no reviews yet.

Be the first to review “omnipaque contrast”

Your email address will not be published. Required fields are marked